Skip to main content
Samer Khaled, MD, Oncology, Duarte, CA, City of Hope Comprehensive Cancer Center

SamerKhaledMD

Oncology Duarte, CA

Hematologic Oncology

Associate Professor

Dr. Khaled is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Khaled's full profile

Already have an account?

Education & Training

  • Brooklyn Hospital Center
    Brooklyn Hospital CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
  • Brooklyn Hospital Center
    Brooklyn Hospital CenterResidency, Internal Medicine, 2002 - 2006
  • Cairo University School of Medicine
    Cairo University School of MedicineClass of 1998

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - 2025
  • FL State Medical License
    FL State Medical License 2005 - 2025
  • NY State Medical License
    NY State Medical License 2008 - 2016
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Effect of Co-Mutations and FLT3-ITD Variant Allele Frequency (VAF) on Response to Quizartinib or Salvage Chemotherapy (SC) in Relapsed/Refractory (R/R) Acute Myeloid L...
    Samer K. Khaled, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...
    Samer K. Khaled, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Characterization of Response and Transfusion Independence in Patients with FLT3-Internal Tandem Duplication (FLT3-ITD)_Mutated Relapsed/Refractory Acute Myeloid Leukem...
    Samer K. Khaled, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Phase 2 Expansion Study of Oral Rigosertib Combined with Azacitidine (AZA) in Patients (Pts) with Higher-Risk (HR) Myelodysplastic Syndromes (MDS): Efficacy and Safety... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • MIPSS70+ V2.0 and Revised Cytogenetics Changes Predict Outcomes of Allogeneic Transplantation with Fludarabine and Melphalan Conditioning in Patients with Myelofibrosis 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Clinical Outcomes of MDS Patients Who Were Allogeneic Hematopoietic Stem Cell Transplant Candidates but Did Not Proceed with Transplantation 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Omeros Corporation Reports Fourth Quarter and Year-End 2020 Financial Results
    Omeros Corporation Reports Fourth Quarter and Year-End 2020 Financial ResultsMarch 1st, 2021
  • City of Hope Clinical and Laboratory Investigators Present New Research at the 60
    City of Hope Clinical and Laboratory Investigators Present New Research at the 60December 4th, 2018
  • City of Hope Doctors Present New Research on CAR T Cell Therapy, Bone Marrow Transplants and Other Treatments for Blood Cancers
    City of Hope Doctors Present New Research on CAR T Cell Therapy, Bone Marrow Transplants and Other Treatments for Blood CancersNovember 19th, 2018
  • Join now to see all

Hospital Affiliations